Hormone Levels During Prostaglandin F2 Infusions for Therapeutic Abortion
LEON SPEROFF,
BURTON V. CALDWELL,
WILLIAM A. BROCK,
GERALD G. ANDERSON and
JOHN C. HOBBINS
Department of Obstetrics and Gynecology, Yale University School of Medicine New Haven, Connecticut 06510
Plasma levels of unconjugated estrone, 17β-estradiol, estriol,progesterone, 17-hydroxyprogesterone, human chorionic gonadotropin(HCG), and human chorionic somatomammotropin (HCS) were measuredin patients 7–20 weeks pregnant receiving prostaglandinF2 infusions for therapeutic abortions. The results indicatethat prostaglandin F2 a does not exert a luteolytic effect interminating pregnancy of 7 weeks or more duration. Significantprogesterone changes were not seen prior to abortion, and noeffect was seen on 17-hydroxyprogesterone levels. There wasa gradual decline in estradiol levels during prostaglandin F2infusion, while significant falls were seen in estriol levelspreceding any changes in estradiol or progesterone. There wereno significant changes in HCG levels, while HCS levels declinedduring the infusion. The data do not rule out the possibilityof a luteolytic effect for prostaglandin F2 in the first fewweeks of pregnancy.
Received April 27, 1971.
This article has been cited by other articles:
C. Murty and P. Adiga Pregnancy suppression by active immunization against gestation-specific riboflavin carrier protein
Science,
April 9, 1982;
216(4542):
191 - 193.
[Abstract][PDF]
H. R. Behrman and G. G. Anderson Prostaglandins in Reproduction
Arch Intern Med,
January 1, 1974;
133(1):
77 - 84.
[Abstract][PDF]